MAR 28, 2020 8:39 AM PDT

The Antibody Test to See if You've Already Had the Coronavirus

WRITTEN BY: Annie Lennon

Knowing whether you’ve had the virus or not may not just reduce your need to panic- but also better help epidemiologists map out the spread of the virus. Now, Henry Schein Inc, the world’s largest distributor of dental and medical supplies, has released an antibody rapid blood test that can tell you if you’ve had the coronavirus before. And it does this in less than 15 minutes. 

Known as Standard Q COVID-19 IgM/IgG Rapid Test, it is a rapid immunochromatography test designed to detect specific IgM and IgG antibodies associated with the novel coronavirus from blood drawn by a pinprick. Detecting the presence of these antibodies, when taken with other information including the presence of symptoms and medical history, the test allows medical professionals to tell whether a person has already been infected by the virus, and whether they may be currently infected by it too. 

Currently available under emergency guidance by the US Food and Drug Administration, Stanley M Bergman, chairman of the Board and CEO of Henry Schein said, “This pandemic is an unprecedented situation, and making rapid diagnostic tools available to health care professionals is critical for detecting and mitigating the spread of the coronavirus.”

Other private companies have also begun selling blood tests capable of detecting coronavirus antibodies. For example, California-based Biomerica sells its tests for less than $10, and has already had orders placed from Europe and the Middle East. Chembio Diagnostics from New York has reportedly received an order for $4 million- worth of antibody tests against the virus, while South Korean test maker, Sugantech, is also reportedly producing tests. 

Meanwhile, researchers are also investigating the viability of antibody tests. Fatima Amanat, a PhD candidate at the Icahn School of Medicine at Mount Sinai, is currently developing tests for first responders and healthcare providers in particular. She said,  “Right now, if you have a highly infectious COVID-19 patient, it's really a problem to send a nurse who is not immune to it already because she’s so susceptible. Our test would be for all the doctors and healthcare providers, to see if they're already immune to it and have antibodies.”



Sources: US Dental Tribune, Vice and Reuters 

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
APR 10, 2020
Cardiology
APR 10, 2020
Drinking Black Tea Reduces Risk of Heart Disease
Black tea is among one of the most commonly consumed beverages around the world. Beyond just being a refreshing and ener ...
APR 11, 2020
Cardiology
APR 11, 2020
Cell Transplant Repairs Brain After Stroke
Using cell therapy, researchers from Lund University in Sweden have successfully restored mobility and a sense of touch ...
APR 19, 2020
Drug Discovery & Development
APR 19, 2020
FDA Approves New Drug for Breast Cancer
The US Food and Drug Administration has approved a new drug, known as tucatinib or Tuksya, as a treatment for advanced f ...
APR 23, 2020
Cancer
APR 23, 2020
Doctors, watch out for unexpected side effects in small clinical trials
Doctors who have patients in small-sized clinical trials that test new cancer drugs should be on the look-out for unexpe ...
MAY 11, 2020
Cancer
MAY 11, 2020
Using Deep Learning to Diagnose Breast Cancer Sub-Types
Cancer and computer programming may not sound like two things that go together. However, advanced programming techniques ...
MAY 25, 2020
Genetics & Genomics
MAY 25, 2020
FDA Approves the First Treatment for Neurofibromatosis 1
In a major breakthrough, the Food and Drug Administration has approved a treatment for a genetic disorder called neurofi ...
Loading Comments...